{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T01:35:51Z","timestamp":1777685751561,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"am","delay-in-days":316,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 AI068617"],"award-info":[{"award-number":["UM1 AI068617"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI121259"],"award-info":[{"award-number":["R01 AI121259"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 MH 105857"],"award-info":[{"award-number":["R01 MH 105857"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Theoretical Biology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jtbi.2025.112086","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T16:32:31Z","timestamp":1741883551000},"page":"112086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Absorbing Markov chain model of PrEP drug adherence to estimate adherence decay rate and probability distribution in clinical trials"],"prefix":"10.1016","volume":"604","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1674-1247","authenticated-orcid":false,"given":"Renee","family":"Dale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyu","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2726-3391","authenticated-orcid":false,"given":"Yingqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtbi.2025.112086_bib0001","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172354","article-title":"Social, structural, behavioral and clinical factors influencing retention in pre-exposure prophylaxis (PrEP) care in mississippi","volume":"12","author":"Arnold","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jtbi.2025.112086_bib0002","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1007\/s10461-017-1958-4","article-title":"Predictors of over-reporting HIV pre-exposure prophylaxis (PrEP) adherence among young men who have sex with men (YMSM) in self-reported versus biomarker data","volume":"22","author":"Baker","year":"2018","journal-title":"AIDS Behav."},{"key":"10.1016\/j.jtbi.2025.112086_bib0003","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3389\/fphar.2018.01290","article-title":"A systematic review of medication adherence thresholds dependent of clinical outcomes","volume":"9","author":"Baumgartner","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.jtbi.2025.112086_bib0004","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1473-3099(16)30534-5","article-title":"Effectiveness and cost-effectiveness of a nurse-delivered intervention to improve adherence to treatment for HIV: a pragmatic, multicentre, open-label, randomised clinical trial","volume":"17","author":"Bruin","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jtbi.2025.112086_bib0005","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/09540121.2017.1360992","article-title":"Exploring strategies for PrEP adherence and dosing preferences in the context of sexualized recreational drug use among MSM: a qualitative study","volume":"30","author":"Closson","year":"2018","journal-title":"AIDS Care"},{"key":"10.1016\/j.jtbi.2025.112086_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200126","article-title":"Estimating epidemiological parameters of a stochastic differential model of HIV dynamics using hierarchical bayesian statistics","volume":"13","author":"Dale","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jtbi.2025.112086_bib0007","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10928-015-9439-8","article-title":"Bayesian population modeling of drug dosing adherence","volume":"42","author":"Fellows","year":"2015","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"issue":"20","key":"10.1016\/j.jtbi.2025.112086_bib0008","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/(SICI)1097-0258(19981030)17:20<2313::AID-SIM935>3.0.CO;2-V","article-title":"A Markov mixed effect regression model for drug compliance","volume":"17","author":"Girard","year":"1998","journal-title":"Stat. Med."},{"key":"10.1016\/j.jtbi.2025.112086_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050537","article-title":"Medication adherence in the general population","volume":"7","author":"Glombiewski","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jtbi.2025.112086_bib0010","first-page":"238","article-title":"Phase 2 study of the safety and tolerability of maraviroc-containing regimens to prevent HIV infection in men who have sex with men (HPTN 069\/ACTG A5305)","volume":"215","author":"Gulick","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jtbi.2025.112086_bib0011","doi-asserted-by":"crossref","unstructured":"Gulick, R. M., Wilkin, T. J., Chen, Y. Q., Landovitz, R. J., Amico, K. R., Young, A. M., Richardson, P., Marzinke, M. A., Hendrix, C. W., Eshleman, S. H., Mcgowan, I., Cottle, L. M., Andrade, A., Marcus, C., Klingman, K. L., Chegu, W., Rinehardt, A. R., Rooney, J. F., Andrew, P., Salata, R. A., Magnus, M., Farley, J. E., Liu, A., Frank, I., Ho, K., Santana, J., Stekler, J. D., Mccauley, M., Mayer, K. H., 2017. Phase 2 study of the safety and tolerability of maraviroc-containing regimens to prevent HIV infection in men who has sex with men (MSM)J. Infect. Dis. 215, 238\u2013246.","DOI":"10.1093\/infdis\/jiw525"},{"key":"10.1016\/j.jtbi.2025.112086_bib0012","doi-asserted-by":"crossref","unstructured":"Haberer, J. E., Kahane, J., Kigozi, I., Emenyonu, N., Hunt, P., Martin, J., Bangsberg, D. R., 2010. Real-time adherence monitoring for HIV antiretroviral therapyAIDS Behav. 14, 1340\u20131346.","DOI":"10.1007\/s10461-010-9799-4"},{"key":"10.1016\/j.jtbi.2025.112086_bib0013","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/pds.4917","article-title":"Opening the black box of the group-based trajectory modeling process to analyze medication adherence patterns: an example using real-world statin adherence data","volume":"29","author":"Hickson","year":"2020","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.jtbi.2025.112086_bib0014","first-page":"677","article-title":"Willingness to take, use of, and indications for pre-exposure prophylaxis among men who have sex with men-20 US cities","volume":"63","author":"Hoots","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jtbi.2025.112086_bib0015","series-title":"Markov Chain Theory and Applications","author":"Isaacson","year":"1976"},{"key":"10.1016\/j.jtbi.2025.112086_bib0016","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1186\/s12889-020-08709-2","article-title":"Real-time monitoring and just-in-time intervention for adherence to pre-exposure prophylaxis among men who have sex with men in china: a multicentre rct study protocol","volume":"20","author":"Jin","year":"2020","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jtbi.2025.112086_bib0017","series-title":"Finite Markov Chains","author":"Kemeny","year":"1976"},{"key":"10.1016\/j.jtbi.2025.112086_bib0018","series-title":"Investing in Medication Adherence Improves Health Outcomes and Health System Efficiency: Adherence to Medicines for Diabetes, Hypertension, and Hyperlipidaemia","author":"Khan","year":"2018"},{"key":"10.1016\/j.jtbi.2025.112086_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033119","article-title":"Limited awareness and low immediate uptake of pre-exposure prophylaxis among men who have sex with men using an internet social networking site","volume":"7","author":"Krakower","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jtbi.2025.112086_bib0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/jamainternmed.2015.4683","article-title":"Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services","volume":"176","author":"Liu","year":"2016","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.jtbi.2025.112086_bib0021","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/jcph.843","article-title":"Markov mixed effects modeling using electronic adherence monitoring records identifies influential covariates to HIV preexposure prophylaxis","volume":"57","author":"Madrasi","year":"2017","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jtbi.2025.112086_bib0022","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3389\/fphar.2019.00785","article-title":"Assessment of demographic and socio-behavioral factors on adherence to HIV pre-exposure prophylaxis using a Markov modeling approach","volume":"10","author":"Mallayasamy","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jtbi.2025.112086_bib0023","unstructured":"Meyer, C., 2002. Matrix analysis and applied linear algebra."},{"key":"10.1016\/j.jtbi.2025.112086_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157742","article-title":"Adherence to pre-exposure prophylaxis for HIV prevention in a clinical setting","volume":"11","author":"Montgomery","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jtbi.2025.112086_bib0025","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s40262-017-0552-2","article-title":"Relationship between adherence rate threshold and drug forgiveness?","volume":"56","author":"Morrison","year":"2017","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jtbi.2025.112086_bib0026","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12981-021-00358-8","article-title":"Defining the optimal cut-point of self-reported art adherence to achieve viral suppression in the era of contemporary HIV therapy: a cross-sectional study","volume":"18","author":"O\u2019halloran","year":"2021","journal-title":"AIDS Res. Ther."},{"issue":"11","key":"10.1016\/j.jtbi.2025.112086_bib0027","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1007\/s10461-020-02881-7","article-title":"Greater levels of self-reported adherence to pre-exposure prophylaxis (PrEP) are associated with increased condomless sex among men who have sex with men","volume":"24","author":"Pasipanodya","year":"2020","journal-title":"AIDS Behav."},{"key":"10.1016\/j.jtbi.2025.112086_bib0028","doi-asserted-by":"crossref","unstructured":"Peng, L., et al., 2019. Willingness to use and adhere to HIV pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) in ChinaInt. J. Environ. Res. Public Health 16, 2620.","DOI":"10.3390\/ijerph16142620"},{"issue":"6","key":"10.1016\/j.jtbi.2025.112086_bib0029","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S1473-3099(17)30106-8","article-title":"Implementation research on HIV adherence interventions: no time to wait","volume":"17","author":"Simoni","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jtbi.2025.112086_bib0030","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jval.2014.06.010","article-title":"Dynamic medication adherence modeling in primary prevention of cardiovascular disease: a Markov microsimulation methods application","volume":"17","author":"Slejko","year":"2014","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.jtbi.2025.112086_bib0031","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/QAI.0000000000002005","article-title":"Brief report: short-term adherence marker to PrEP predicts future nonretention in a large PrEP demo project: implications for point-of-care adherence testing","volume":"81","author":"Spinelli","year":"2019","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"4","key":"10.1016\/j.jtbi.2025.112086_bib0032","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s40268-017-0216-6","article-title":"The adherence rate threshold is drug specific","volume":"17","author":"Stauffer","year":"2017","journal-title":"Drugs R&D"},{"key":"10.1016\/j.jtbi.2025.112086_bib0033","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s11121-017-0799-8","article-title":"Risk perception, sexual behaviors, and PrEP adherence among substance-using men who have sex with men: a qualitative study","volume":"18","author":"Storholm","year":"2017","journal-title":"Prev. Sci."},{"issue":"9","key":"10.1016\/j.jtbi.2025.112086_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004097","article-title":"Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: results from a prospective cohort study","volume":"19","author":"Tapsoba","year":"2022","journal-title":"PLoS Med."},{"key":"10.1016\/j.jtbi.2025.112086_bib0035","unstructured":"The MathWorks Inc.,2021. MATLAB version: 9.10.0.1710957 (R2022a). Natick, Massachusetts, The MathWorks Inc. https:\/\/www.mathworks.com."},{"key":"10.1016\/j.jtbi.2025.112086_bib0036","series-title":"Matrix Iterative Analysis","author":"Varga","year":"2002"},{"issue":"2","key":"10.1016\/j.jtbi.2025.112086_bib0037","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s12561-019-09232-8","article-title":"Clustering functional data with application to electronic medication adherence monitoring in HIV prevention trials","volume":"11","author":"Zhu","year":"2019","journal-title":"Stat. Biosci."},{"key":"10.1016\/j.jtbi.2025.112086_bib0038","doi-asserted-by":"crossref","unstructured":"Zijp, T. R. et al., Smart medication adherence monitoring in clinical drug trials: a prerequisite for personalised medicine?eClinicalMedicine. Vol. 15.","DOI":"10.1016\/j.eclinm.2019.08.013"}],"container-title":["Journal of Theoretical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022519325000529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022519325000529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:53:06Z","timestamp":1777452786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022519325000529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":38,"alternative-id":["S0022519325000529"],"URL":"https:\/\/doi.org\/10.1016\/j.jtbi.2025.112086","relation":{},"ISSN":["0022-5193"],"issn-type":[{"value":"0022-5193","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Absorbing Markov chain model of PrEP drug adherence to estimate adherence decay rate and probability distribution in clinical trials","name":"articletitle","label":"Article Title"},{"value":"Journal of Theoretical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtbi.2025.112086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"112086"}}